Viking Therapeutics
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
VKTX Key Statistics
Stock Snapshot
As of today, Viking Therapeutics(VKTX) shares are valued at $33.86. The company's market cap stands at 4.16B, with a P/E ratio of -7.25.
On 2026-08-12, Viking Therapeutics(VKTX) stock moved within a range of $33.61 to $34.85. With shares now at $33.86, the stock is trading +0.7% above its intraday low and -2.8% below the session's peak.
Trading volume for Viking Therapeutics(VKTX) stock has reached 1.01M, versus its average volume of 1.89M.
Over the past 52 weeks, Viking Therapeutics(VKTX) stock has traded between a high of $43.15 and a low of $22.96.
Over the past 52 weeks, Viking Therapeutics(VKTX) stock has traded between a high of $43.15 and a low of $22.96.
VKTX News
In July 2026, Viking Therapeutics reported a second-quarter net loss of US$128.02 million and a six-month net loss of US$286.35 million, while simultaneously ra...
Analyst ratings
90%
of 20 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.